Riskpilot← Back to searchSign inGet full accessONEMED A/S
A/SActiveCVR 19846679Kappa 3Wholesale of pharmaceutical and medical goods · NACE 4646Est. 199775 employees
Revenue 2024
DKK 307,4M
-15% vs 2023
EBITDA margin
-0.6%
-110% vs 2023
Equity ratio
41.3%
Financial strength
Net profit 2024
DKK -15,1M
-519% vs 2023
| Revenue | DKK 307,4M | -15% |
| EBITDA | DKK -1,8M | -110% |
| Net profit | DKK -15,1M | -519% |
| Total assets | DKK 440,4M | +11% |
| Equity | DKK 181,9M | -8% |
| Employees | 75 | — |
Legal name
ONEMED A/S
CVR number
19846679
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. februar 1997
Share capital
DKK 1.500.000
Employees
75 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsen eller af to bestyrelsesmedlemmer i forening eller af direktøren sammen med et medlem af bestyrelsen i forening eller en be-fuldmægtiget samt et medlem af bestyrelsen i forening. Direktøren er bemyndiget til at tegne selskabet i forhold, der anses som værende led i den daglige ledelse.
Company purpose
Selskabets formål er at producere og drive handel med hospitals- og sygeplejeartikler samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Address
Kappa 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.746 | 34.979 | 39.437 | 37.022 | 35.930 | 50.269 | 425.168 | 509.404 | 444.644 | 403.207 | 361.427 | 307.440 |
| Staff expenses | -24.969 | -26.862 | -29.318 | -29.754 | -31.183 | -32.347 | -36.879 | -37.123 | -40.010 | -42.329 | -41.289 | -41.608 |
| EBITDA | -1.223 | 8.117 | 10.119 | 7.268 | 4.747 | 17.922 | 27.567 | 44.309 | 34.025 | 23.016 | 18.341 | -1.755 |
| Depreciation & amort. | -243 | -285 | -305 | -306 | -320 | -265 | -274 | -302 | -2.001 | -4.512 | -5.134 | -4.745 |
| EBIT | -1.466 | 7.831 | 9.814 | 6.962 | 4.427 | 17.657 | 27.293 | 44.007 | 32.024 | 18.504 | 13.207 | -6.500 |
| Net financials | 1.174 | 1.608 | 1.779 | 2.281 | 2.286 | 2.446 | 2.861 | 2.312 | 234 | -3.124 | -8.645 | -12.197 |
| Profit before tax | -291 | 9.439 | 11.594 | 9.244 | 6.713 | 20.103 | 30.154 | 46.319 | 32.258 | 15.380 | 4.562 | -18.697 |
| Tax | -51 | 2.312 | 2.751 | 1.759 | 1.581 | 4.440 | 6.662 | 10.200 | 7.673 | 3.829 | 957 | -3.582 |
| Net profit | -241 | 7.128 | 8.843 | 7.485 | 5.132 | 15.663 | 23.492 | 36.119 | 24.585 | 11.551 | 3.605 | -15.115 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 90.654 | 109.328 | 124.367 | 120.742 | 156.210 | 168.320 | 193.449 | 225.940 | 237.515 | 403.685 | 395.861 | 440.388 |
| Equity | 53.399 | 60.527 | 69.370 | 76.855 | 81.988 | 97.651 | 121.143 | 157.262 | 181.847 | 193.398 | 197.003 | 181.888 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.967 | 2.939 | 3.050 | 3.216 | 3.378 |
| Short-term debt | 37.254 | 48.801 | 54.997 | 43.887 | 74.222 | 70.669 | 72.306 | 65.712 | 51.480 | 206.379 | 195.341 | 221.487 |
| Total debt | 37.254 | 48.801 | 54.997 | 43.887 | 74.222 | 70.669 | 72.306 | 68.678 | 54.419 | 209.429 | 198.557 | 224.865 |
EBITDA margin
-0.6%
This company
15.8%
Market median
-104% vs market
20132024
Equity ratio
41.3%
This company
38.2%
Market median
+8% vs market
20132024
Return on equity
-8.3%
This company
18.4%
Market median
-145% vs market
20132024
Net profit margin
-4.9%
This company
8.1%
Market median
-160% vs market
20132024
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20132024
Debt / equity
1.42×
This company
0.62×
Market median
-129% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KR Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
JK Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
HF Chief Executive Officer | Chief Executive Officer | 2000 | — | — |
PJ Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
BJ Chief Executive Officer | Chief Executive Officer | 2001 | — | — |
MN Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2013 | — | — | |
| Chairman | 2008 | — | — | |
| Board of Directors | 2002 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2005 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 1997 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 1997 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 | |
| Individual | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ONEMED A/S 
ZiboCare A/SBoard members of ONEMED A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirstine Rylev Holm | Chief Executive Officer | 0 companies |
| Jan Knoph | Chief Executive Officer | 0 companies |
| Heidi Frandsen | Chief Executive Officer | 0 companies |
| Peter Jürgensen | Chief Executive Officer | 0 companies |
| Bent Jørgensen | Chief Executive Officer | 0 companies |
| Morten Nielsen | Chief Executive Officer | 0 companies |
| Thomas Philip Moss | Board of Directors | 0 companies |
| Lottie Saks | Board of Directors | 0 companies |
| Andreas Gunnar Göthberg | Chairman | 0 companies |
| Tina Lybech | Board of Directors | 0 companies |
| Carl Johan Falk | Chairman | 0 companies |
| Ales Zobec | Board of Directors | 0 companies |
| Birgit Andersen | Board of Directors | 0 companies |
| Leena Anita Schnapp | Board of Directors | 0 companies |
| Jorma Juhani Turunen | Chairman | 0 companies |
| Lars Olof Ragnar Ingman | Board of Directors | 0 companies |
| Anni Birthe Jørgensen | Board of Directors | 0 companies |
| Michael Bugge Vogt | Board of Directors | 0 companies |
| Niclas Köhler | Board of Directors | 0 companies |
| Pieter-Jan Jongeling | Chairman | 0 companies |
| Ola Burmark | Board of Directors | 0 companies |
| Pia Jørgensen | Board of Directors | 0 companies |